
Optical Bonding Process Change in Surgical Displays: What Should OEMs Revalidate Before Approval?
An optical bonding process change should be treated as a controlled configuration change, not simply as a cosmetic upgrade. OEMs should define the approved baseline, identify what has changed, revalidate the affected optical, mechanical, surface and reliability characteristics, review updated supplier evidence, and control the transition between old and new production batches.


